BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 386094)

  • 1. Structure and conformation of glucocorticoids.
    Schmit JP; Rousseau GG
    Monogr Endocrinol; 1979; 12():79-95. PubMed ID: 386094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational analysis of sterols: comparison of X-ray crystallographic observations with data from other sources.
    Duax WL; Griffin JF; Rohrer DC; Weeks CM
    Lipids; 1980 Sep; 15(9):783-92. PubMed ID: 7421432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanics and X-ray crystal structure investigations on conformations of 11 beta substituted 4,9-dien-3-one steroids.
    Bohl M; Schubert G; Ponsold K; Reck G; Höhne E; Simon K
    J Mol Graph; 1989 Sep; 7(3):122-9, 153. PubMed ID: 2488852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of action of steroid antagonists: insights from crystallographic studies.
    Duax WL; Griffin JF; Weeks CM; Wawrzak Z
    J Steroid Biochem; 1988 Oct; 31(4B):481-92. PubMed ID: 3059053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure-activity relationships of cardiotonic steroids using empirical molecular electrostatic potentials and semiempirical molecular orbital calculations.
    Bohl M; Ponsold K; Reck G
    J Steroid Biochem; 1984 Oct; 21(4):373-9. PubMed ID: 6492795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of 1 alpha,3 alpha-trimethylene-2',5-epoxyandrostane-3 beta, 17 beta-diol 17-propionate methanol solvate (1/0.5).
    Duax WL; Strong PD; Wawrzak Z; Gałdecki Z; Grochulski P
    Acta Crystallogr C; 1988 Aug; 44 ( Pt 8)():1430-3. PubMed ID: 3271551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships in glucocorticoids.
    Wolff ME
    Monogr Endocrinol; 1979; 12():97-107. PubMed ID: 492176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
    Duax WL; Swenson DC; Strong PD; Korach KS; McLachlan J; Metzler M
    Mol Pharmacol; 1984 Nov; 26(3):520-5. PubMed ID: 6548545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of the orientation of the C9 substituent to cannabinoid activity.
    Reggio PH; Greer KV; Cox SM
    J Med Chem; 1989 Jul; 32(7):1630-5. PubMed ID: 2738895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lead structure in cardiac glycosides is 5 beta, 14 beta-androstane-3 beta 14-diol.
    Schönfeld W; Weiland J; Lindig C; Masnyk M; Kabat MM; Kurek A; Wicha J; Repke KR
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):414-26. PubMed ID: 4033807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D: concerning the relationship between molecular topology and biological function.
    Okamura WH; Norman AW; Wing RM
    Proc Natl Acad Sci U S A; 1974 Oct; 71(10):4194-7. PubMed ID: 4372612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure--activity relationships for glucocorticoids--III. Structural and conformational study of the rings and side-chain of steroids which bind to the glucocorticoid receptor.
    Schmit JP; Rousseau GG
    J Steroid Biochem; 1978 Oct; 9(10):909-20. PubMed ID: 745393
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular conformation, receptor binding, and hormone action of natural and synthetic estrogens and antiestrogens.
    Duax WL; Griffin JF; Weeks CM; Korach KS
    Environ Health Perspect; 1985 Sep; 61():111-21. PubMed ID: 3905370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A-ring conformational stability and progesterone-receptor binding affinity of 4-en-3-one steroids.
    Bohl M; Kaufmann G; Hübner M; Reck G; Kretschmer RG
    J Steroid Biochem; 1985 Dec; 23(6A):895-900. PubMed ID: 4094417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure--activity relationships for glucocorticoids--IV. Effects of substituents on the overall shape of steroids which bind to the glucocorticoid receptor.
    Schmit JP; Rousseau GG
    J Steroid Biochem; 1978 Oct; 9(10):921-7. PubMed ID: 745394
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular structures, conformational analysis, and preferential modes of binding of 3-aroyl-2-arylbenzo[b]thiophene estrogen receptor ligands: LY117018 and aryl azide photoaffinity labeling analogs.
    Kym PR; Anstead GM; Pinney KG; Wilson SR; Katzenellenbogen JA
    J Med Chem; 1993 Nov; 36(24):3910-22. PubMed ID: 8254621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of (+/-)-encecanescin.
    Abboud KA; Simonsen SH
    Acta Crystallogr C; 1990 Aug; 46 ( Pt 8)():1563-6. PubMed ID: 2222936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of 5 beta-pregnane-3 alpha, 6 alpha, 17 alpha-triol triacetate.
    Grochulski P; Wawrzak Z; Gałdecki Z; Duax WL; Strong PD
    Acta Crystallogr C; 1992 Dec; 48 ( Pt 12)():2247-9. PubMed ID: 1292514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B3LYP/6-311++G** study of alpha- and beta-D-glucopyranose and 1,5-anhydro-D-glucitol: 4C1 and 1C4 chairs, (3,O)B and B(3,O) boats, and skew-boat conformations.
    Appell M; Strati G; Willett JL; Momany FA
    Carbohydr Res; 2004 Feb; 339(3):537-51. PubMed ID: 15013391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural requirements for the action of steroids as quenchers of albumin fluorescence.
    Romeu AM; Martino EE; Stoppani AO
    Biochim Biophys Acta; 1975 Dec; 409(3):376-86. PubMed ID: 1239298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.